La Jolla, CA and Washington, DC (PRWEB) May 10, 2012
Congressman and House Energy and Commerce Committee Chairman Fred Upton, R-Mich., was honored yesterday by CHI, the California Healthcare Institute, with the organization’s chairman’s award. The award was presented by CHI Chairman Carl W. Hull, president and chief executive officer of Gen-Probe Inc., and David L. Gollaher, Ph.D., president and CEO of CHI.
“Congressman Upton has been a leader in supporting our biomedical industry, especially efforts to make the FDA regulatory process more efficient and predictable,” Gollaher said. “We are pleased to recognize him for his continued leadership with respect to regulatory reform and biomedical research.”
Upton was first elected to the U.S. House of Representatives, representing southwest Michigan and the cities of Kalamazoo and Benton Harbor-St. Joseph, in 1986. In 2010, Upton was selected by his House colleagues to serve as chairman of the Committee on Energy and Commerce, which has jurisdiction over matters concerning healthcare, energy, the environment, telecommunications, commerce, manufacturing, and trade, as well as oversight and investigations.
Upton has a long history of support for policies to promote biomedical research, investment and innovation. As a longtime member of the Energy and Commerce Committee and a former member of its Health Subcommittee, Upton has pushed for greater emphasis on biomedical research to improve public health. In 1996, in response to calls for FDA reform and concerns that U.S. manufacturers were being forced to move facilities and jobs overseas because the agency did not authorize exportation in a timely manner, Upton led efforts culminating in enactment of the FDA Export Reform and Enhancement Act. And as chairman, Upton has presided over efforts this Congress to bolster American drug and device innovation through policies that encourage the FDA to improve the consistency and predictability of its product review processes, such as through improved communications with industry and an improved benefit-risk framework. In this regard, he has played a key role in reauthorizing critical FDA user fee and related legislation.
"I am honored to receive this award from the California Healthcare Institute,” Upton said. “CHI and its members represent an industry that provides highly valuable jobs to California and beyond. It is through their commitment to research and development that patients receive access to life-saving products. I remain committed to advocating for policies that create a favorable environment for innovators to conduct business and create jobs."
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is http://www.chi.org. Follow us on Twitter @calhealthcare and Facebook.
Photos Available Upon Request